产时因素提升严重母体并发症预测价值
该回顾性队列研究纳入8家医院2016年7月至2020年6月分娩的33,770例足月单胎、临产并进入第二产程的孕妇,比较扩展产科合并症评分(EOCS)单用与联合产时因素的预测效能。结果显示联合模型的曲线下面积(AUC)由0.676升至0.729(P<.001),提示产时因素可改善第二产程开始时对严重母体并发症的预测。
要点
- EOCS联合产时因素后AUC从0.676升至0.729(P<.001)
- 联合模型中与严重母体并发症相关的因素包括EOCS、产程时长和胎粪污染羊水
- 严重母体并发症在33,770例分娩中发生498例(1.5%)
核心结论
- 在第二产程开始时,将产时因素与经验证的EOCS联合可提高对严重母体并发症的预测能力,体现母体风险在产程中动态演变。
研究设计与样本
- 单一家医疗系统8家医院的回顾性队列研究,纳入2016年7月1日至2020年6月30日足月单胎、临产入院并达第二产程的产妇,共33,770例分娩。
- 医院分为训练集(n=4)与测试集(n=4),以评估模型预测性能;测试集n=15,350。
- 比较EOCS单独模型与EOCS联合产次及产时因素(引产或加强宫缩、产程时长、胎膜早破时间延长、胎粪污染羊水、孕周)的logistic回归模型。
主要发现
- 严重母体并发症发生于498例(1.5%)分娩。
- 测试集中EOCS单独模型AUC为0.676(95%CI 0.636-0.716),155例(71%)事件发生于预测风险中位数以上者。
- 联合产时因素后AUC升至0.729(95%CI 0.693-0.764),171例(78%)事件发生于预测风险中位数以上者。
- 联合模型中与严重母体并发症显著相关的因素为EOCS、产程时长及胎粪污染羊水。
关键数值与推荐
- 联合模型AUC显著高于EOCS单独模型(P<.001)。
- 研究在EOCS预测为低风险的产妇亚组中也进行了类似的模型比较。
临床怎么用
- 在第二产程开始时,除合并症评分外应结合产程时长、胎粪污染羊水等产时因素动态评估严重母体并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rates of severe maternal morbidity and mortality in the United States exceed those in other high-income nations. To aid providers and hospitals in recognizing the risk factors, there have been multiple attempts to develop stratification systems for morbidity based on maternal comorbidities. However, most women giving birth are healthy and do not have comorbidities to suggest that they are at an increased risk for severe maternal morbidity. There are small but inherent maternal risks to labor, and the events after admission may further influence a woman's risk for morbidity even for those initially at a low risk. OBJECTIVE: To determine if the incorporation of intrapartum factors known at the start of the second stage of labor improves the predictive performance of a comorbidity-based risk tool for severe maternal morbidity. STUDY DESIGN: This is a retrospective cohort study of women at 8 hospitals in a single health system between July 1, 2016, and June 30, 2020. The women had term, singleton gestations and were admitted in labor and reached the second stage. The primary outcome was severe maternal morbidity. We compared logistic regression models using a validated risk-scoring tool (the Expanded Obstetric Comorbidity Score, which uses diagnosis codes for maternal comorbidities and pregnancy characteristics to predict maternal morbidity) with a model that included the Expanded Obstetric Comorbidity Score combined with parity and intrapartum factors. The intrapartum factors included labor induction or augmentation, length of labor, prolonged rupture of membranes, the presence of meconium-stained amniotic fluid, and gestational age. The hospitals were divided into a training (n=4) and testing (n=4) set to evaluate the predictive model performance. Discrimination was assessed by calculating the area under the receiver operating curve and calibration via calibration plots. Similar model comparisons were performed in a subgroup of women, who the Expanded Obstetric Comorbidity Score predicted to be at low risk for morbidity. RESULTS: This analysis included 33,770 deliveries from the 8 hospitals; severe maternal morbidity occurred in 498 (1.5%) deliveries. The model performance is reported among the testing set (n=15,350). Using the Expanded Obstetric Comorbidity Score alone, the area under the receiver operating curve was 0.676 (95% confidence interval, 0.636-0.716) and 155 (71%) events occurred among individuals above the median predicted risk. When combining intrapartum factors, the area under the receiver operating curve increased to 0.729, (95% confidence interval, 0.693-0.764) and 171 (78%) events occurred among individuals above the median predicted risk. The significant factors that were associated with severe maternal morbidity in this combined model included the Expanded Obstetric Comorbidity Score, length of labor, and the presence of meconium-stained amniotic fluid. The area under the receiver operating curve for the model with intrapartum factors was significantly higher than the models using the Expanded Obstetric Comorbidity Score alone (P<.001). CONCLUSION: The incorporation of intrapartum factors along with a validated risk tool (Expanded Obstetric Comorbidity Score) improved the ability to predict severe maternal morbidity at the start of the second stage. These findings emphasize the evolution of a woman's risk during her labor course and suggests that the prediction of maternal risk can be improved by considering intrapartum factors.
引用
- Clapp MA, James KE, McCoy TH, et al. The value of intrapartum factors in predicting maternal morbidity. Am J Obstet Gynecol MFM. 2021. PMID: 34517146. doi:10.1016/j.ajogmf.2021.100485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。